BioCentury
ARTICLE | Management Tracks

Novartis’ Narasimhan joins Anthropic board

BioCentury’s latest roundup of management changes across the biotech industry

April 15, 2026 12:42 AM UTC

With the belief that healthcare and life sciences represent one of the greatest opportunities for artificial intelligence to improve humans’ quality of life, Anthropic PBC has appointed Vas Narasimhan, the CEO of Novartis AG (SIX:NOVN; NYSE:NVS), to its board.

A Novartis employee since 2005, Narasimhan has been CEO since 2018. Anthropic said he has “spent his career stewarding breakthrough science responsibly,” in line with its mission to balance shareholder interests with its public benefit goals...